{"id":"https://openalex.org/W4388048276","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","title":"1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan","display_name":"1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388048276","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1418"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1418","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1576.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1576.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075345722","display_name":"Jacob Peter Zaemes","orcid":"https://orcid.org/0009-0007-4390-5490","observed_orcids":["https://orcid.org/0009-0007-4390-5490"]},"institutions":[{"id":"https://openalex.org/I2802534011","display_name":"MedStar Georgetown University Hospital","ror":"https://ror.org/03ja1ak26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802534011","https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Zaemes","raw_affiliation_strings":["MedStar Georgetown University Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedStar Georgetown University Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I2802534011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066162133","display_name":"Shaked Lev Ari","orcid":"https://orcid.org/0000-0003-1791-0644","observed_orcids":["https://orcid.org/0000-0003-1791-0644"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaked Lev Ari","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lauren Pascual","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Pascual","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089499530","display_name":"Opeyemi A. Jegede","orcid":"https://orcid.org/0000-0003-1763-8214","observed_orcids":["https://orcid.org/0000-0003-1763-8214"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Opeyemi A Jegede","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Natali Arias-Orozco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natali Arias-Orozco","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017772744","display_name":"Brittany Sinclaire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brittany Sinclaire","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexandra DellaPia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra DellaPia","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081286799","display_name":"Rachel Zemel","orcid":"https://orcid.org/0000-0002-3942-7285","observed_orcids":["https://orcid.org/0000-0002-3942-7285"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel A Zemel","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100754338","display_name":"Yili Zhang","orcid":"https://orcid.org/0009-0008-2784-7195","observed_orcids":["https://orcid.org/0009-0008-2784-7195"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yili Zhang","raw_affiliation_strings":["Georgetown University, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University, Washington, DC, USA","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079444927","display_name":"Samir N. Gupta","orcid":"https://orcid.org/0000-0003-4192-5002","observed_orcids":["https://orcid.org/0000-0003-4192-5002"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samir Gupta","raw_affiliation_strings":["Georgetown University, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University, Washington, DC, USA","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109266198","display_name":"Adil Alaoui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adil Alaoui","raw_affiliation_strings":["Innovation Center for Biomedical Informatics at Georgetown University, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovation Center for Biomedical Informatics at Georgetown University, Washington, DC, USA","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025036628","display_name":"Andrew Ip","orcid":"https://orcid.org/0000-0003-0456-5618","observed_orcids":["https://orcid.org/0000-0003-0456-5618"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Ip","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B Atkins","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017334876","display_name":"Meredith M. Regan","orcid":"https://orcid.org/0000-0002-2428-6109","observed_orcids":["https://orcid.org/0000-0002-2428-6109"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith Regan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058692226","display_name":"Neil J. Shah","orcid":"https://orcid.org/0000-0001-5752-6212","observed_orcids":["https://orcid.org/0000-0001-5752-6212"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil J Shah","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, Washington, DC, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":1.9462,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.86534216,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"A1576","last_page":"A1577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-free-survival","display_name":"treatment-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5789999961853027},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.625},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6790000200271606},{"id":"https://openalex.org/keywords/restricted-mean-survival-time","display_name":"restricted mean survival time","score":0.8209999799728394},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.7039999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.46399998664855957},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6930000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8390895128250122},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.670475959777832},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.641355037689209},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5566321015357971},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5371229648590088},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5319443345069885},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4860277771949768},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47743162512779236},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4629761576652527},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4602119028568268},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4522635340690613},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4194354712963104},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.41791489720344543},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3594137728214264},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.09748890995979309}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1418","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1576.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:543f662ef85345d892a18d4460b414d0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/543f662ef85345d892a18d4460b414d0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1418","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1418","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1576.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388048276.pdf","grobid_xml":"https://content.openalex.org/works/W4388048276.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W3212125694","https://openalex.org/W4304807333"],"related_works":["https://openalex.org/W4311145146","https://openalex.org/W3028601596","https://openalex.org/W4384130491","https://openalex.org/W3212125694","https://openalex.org/W4400272222","https://openalex.org/W2972424818","https://openalex.org/W2947528870","https://openalex.org/W3208166991","https://openalex.org/W4381715763","https://openalex.org/W4411006414"],"abstract_inverted_index":{"Background":[0],"Patients":[1],"(pts)":[2,467],"receiving":[3,66,88,261],"immune":[4,430],"checkpoint":[5,431],"inhibitor":[6],"(ICI)":[7],"therapy":[8,68,90,116,122,165,237,254,297,372,378],"can":[9],"experience":[10],"periods":[11],"of":[12,45,86,115,163,173,242,266,277,303,321,371,389,423],"prolonged":[13,390],"disease":[14],"control":[15],"after":[16],"treatment":[17,118,291,318,335,522],"discontinuation.":[18],"Previous":[19],"studies":[20],"have":[21],"used":[22],"treatment-free":[23],"survival":[24,195,419,457,512],"(TFS)":[25,458],"to":[26,160,171,180,358],"characterize":[27],"this":[28],"interval":[29],"in":[30,60,218,225,247,343,362,379,392,433,459,481,528],"pts":[31,87,201,206,344],"with":[32,62,105,202,207,232,259,274,300,336,345,368,376,425,429,469,514],"advanced":[33,426],"melanoma":[34,427],"(AM)":[35],"and":[36,64,94,101,107,111,117,166,204,222,269,280,295,306,347,373],"non-small":[37,461],"cell":[38,462],"lung":[39,463,526],"cancer":[40,464,527],"(NSCLC).1\u20133":[41],"To":[42],"date,":[43],"evaluation":[44],"TFS":[46,58,146,214,241,276,302,320,325,340,365,391],"has":[47],"largely":[48],"been":[49],"performed":[50],"using":[51,73,81,141,191],"clinical":[52,363],"trial":[53],"data.":[54,76],"Here,":[55],"we":[56],"report":[57],"outcomes":[59,513],"patients":[61,258,311,424,466],"AM":[63,106,203,220,233,260,346],"NSCLC":[65,108,208,227,288,310,348],"ICI":[67,89,129,164,169,236,271,290,355],"over":[69,349,420],"a":[70,82,240,329],"3-year":[71,212,351],"timespan":[72],"real-world":[74],"registry":[75,85],"Methods":[77],"Data":[78],"were":[79,109,139,209],"obtained":[80],"multi-site":[83],"immuno-oncology":[84],"from":[91,158,168,353],"Georgetown-MedStar":[92],"Health":[93,97],"Hackensack":[95],"Meridian":[96],"between":[98,152,184],"January":[99],"2011":[100],"April":[102],"2018.":[103],"Pts":[104,231],"included":[110],"sub-stratified":[112],"by":[113,541],"line":[114],"type":[119],"for":[120,156,334,523],"first-line":[121,238,262,317,521],"as":[123,149,252,292,316,328,520],"follows:":[124],"NSCLC:":[125],"anti-PD-(L)1":[126,314],"monotherapy;":[127],"AM:":[128],"monotherapy":[130,315],"(anti-CTLA-4":[131],"or":[132,134,178,255,476],"anti-PD-(L)1)":[133],"the":[135,142,150,219,226,264,287,350,359,542],"combination.":[136],"Survival":[137],"functions":[138],"estimated":[140,190],"Kaplan-Meier":[143],"(KM)":[144],"method.":[145],"was":[147,189,215,272,298,341,374,539],"defined":[148],"area":[151,183],"two":[153],"KM":[154,185],"curves":[155],"time":[157,167,196],"initiation":[159,170,172],"final":[161],"dose":[162],"subsequent":[174],"systemic":[175],"therapy,":[176,263],"death,":[177],"referral":[179],"hospice.":[181],"The":[182,211],"curves,":[186],"including":[187],"TFS,":[188],"(3-year)":[192],"restricted":[193],"mean":[194,213,275,301,339],"(RMST).":[197],"Results":[198],"Two-hundred":[199],"ninety":[200],"408":[205],"included.":[210],"9.2":[216],"months":[217,224,244],"cohort":[221,228],"4.0":[223],"(table":[229],"1).":[230,285],"who":[234,249,312],"received":[235,250,313],"achieved":[239],"10.58":[243],"vs":[245],"8.43":[246],"those":[248],"it":[251],"second-line":[253],"later.":[256],"Among":[257],"use":[265],"anti-CTLA-4,":[267],"anti-PD-(L)1,":[268],"combination":[270,377],"associated":[273,299],"8.13,":[278],"8.56,":[279],"15.04":[281],"months,":[282,308],"respectively":[283],"(figure":[284],"In":[286],"cohort,":[289],"first-line,":[293],"second-line,":[294],"later-line":[296],"4.94,":[304],"4.25,":[305],"1.98":[307],"respectively.":[309],"had":[319],"4.43":[322],"months.":[323],"Conclusions":[324],"is":[326],"emerging":[327],"unique,":[330],"clinically":[331],"meaningful":[332],"endpoint":[333],"ICIs.":[337],"Marked":[338],"seen":[342],"period":[352],"first":[354],"initiation,":[356],"comparable":[357],"intervals":[360],"observed":[361],"trials.1\u20133":[364],"generally":[366],"decreased":[367],"later":[369],"lines":[370],"greater":[375],"AM.":[380],"Future":[381],"analysis":[382],"will":[383],"focus":[384],"on":[385],"identifying":[386],"additional":[387],"predictors":[388],"these":[393],"cohorts.":[394],"References":[395],"Regan":[396],"MM,":[397],"Mantia":[398],"CM,":[399],"Werner":[400],"L,":[401,500,504],"Tarhini":[402],"AA,":[403],"Larkin":[404],"J,":[405,409,443,445,451,453],"Hodi":[406],"FS,":[407],"Wolchok":[408],"Postow":[410],"MA,":[411],"Stwalley":[412],"B,":[413],"Moshyk":[414],"A,":[415,508],"Ritchings":[416],"C.":[417],"Treatment-free":[418,456],"extended":[421],"follow-up":[422],"treated":[428,468],"inhibitors":[432],"CheckMate":[434,482,529],"067.":[435],"J":[436,531],"Immunother":[437],"Cancer.":[438],"2021;9:e003743.":[439],"Peters":[440],"S,":[441,447],"Penrod":[442],"Li":[444],"Lubinga":[446],"Gupta":[448],"R,":[449,496,506],"Bushong":[450],"Rizzo":[452],"Ramalingam":[454],"S.":[455],"metastatic":[460,524],"(mNSCLC)":[465],"1L":[470],"nivolumab":[471,515],"plus":[472,516],"ipilimumab":[473,517],"(NIVO+":[474],"IPI)":[475],"platinum":[477],"doublet":[478],"chemotherapy":[479,519],"(PDC)":[480],"(CM)":[483],"227.":[484,530],"Ann":[485],"Oncol.":[486,533],"2022;33:S32-S33.":[487],"Brahmer":[488],"JR,":[489],"Lee":[490],"JS,":[491],"Ciuleanu":[492],"TE,":[493],"Bernabe":[494],"Caro":[495],"Nishio":[497],"M,":[498],"Urban":[499],"Audigier-Valette":[501],"C,":[502],"Lupinacci":[503],"Sangha":[505],"Pluzanski":[507],"Burgers":[509],"J.":[510],"Five-year":[511],"versus":[518],"non-small-cell":[525],"Clin":[532],"2022;41:1200\u20131212":[534],"Ethics":[535],"Approval":[536],"This":[537],"study":[538],"approved":[540],"Georgetown":[543],"University":[544],"Medical":[545],"Center":[546],"Institutional":[547],"Review":[548],"Board;":[549],"approval":[550],"number":[551],"MODCR00002093.":[552]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}